Literature DB >> 22581068

Membrane interaction and antibacterial properties of chensinin-1, an antimicrobial peptide with atypical structural features from the skin of Rana chensinensis.

Dejing Shang1, Yue Sun, Che Wang, Shi Wei, Lijie Ma, Li Sun.   

Abstract

Many antimicrobial peptides from amphibian skin have been purified and structurally characterized and may be developed as therapeutic agents. Here we describe the antibacterial properties and membrane interaction of chensinin-1, a cationic arginine/histidine-rich antimicrobial peptide, from the skin secretions of Rana chensinensis. The amino acid composition, sequence, and atypical structure of chensinin-1 differ from other known antimicrobial peptides from amphibian skin. Chensinin-1 exhibited selective antimicrobial activity against Gram-positive bacteria, was inactive against Gram-negative bacteria, and had no hemolytic activity on human erythrocytes. The CD spectra for chensinin-1 indicated that the peptide adopted an aperiodic structure in water and a conformational structure with 20 % β-strands, 8 % α-helices, and the remaining majority of random coils in the trifluoroethanol or SDS solutions. Time-kill kinetics against Gram-positive Bacillus cereus demonstrated that chensinin-1 was rapidly bactericidal at 2× MIC and PAE was found to be >5 h. Chensinin-1 caused rapid and large dye leakage from negatively charged model vesicles. Furthermore, membrane permeation assays on intact B. cereus indicated that chensinin-1 induced membrane depolarization in less than 1 min and followed to damage the integrity of the cytoplasmic membrane and resulted in efflux of molecules from cytoplasma. Hence, the primary target of chensinin-1 action was the cytoplasmic membrane of bacteria. Chensinin-1 was unable to overcome bacterial resistance imposed by the lipopolysaccharide leaflet, the major constituent of the outer membrane of Gram-negative bacteria. Lipopolysaccharide induced oligomerization of chensinin-1, thus preventing its translocation across the outer membrane.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581068     DOI: 10.1007/s00253-012-4148-3

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  7 in total

1.  Molecular Design, Structural Analysis and Antifungal Activity of Derivatives of Peptide CGA-N46.

Authors:  Rui-Fang Li; Zhi-Fang Lu; Ya-Nan Sun; Shi-Hua Chen; Yan-Jie Yi; Hui-Ru Zhang; Shuo-Ye Yang; Guang-Hai Yu; Liang Huang; Chao-Nan Li
Journal:  Interdiscip Sci       Date:  2016-05-10       Impact factor: 2.233

Review 2.  pH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic Agents.

Authors:  Erum Malik; Sarah R Dennison; Frederick Harris; David A Phoenix
Journal:  Pharmaceuticals (Basel)       Date:  2016-11-01

3.  Antimicrobial and anti-inflammatory activities of three chensinin-1 peptides containing mutation of glycine and histidine residues.

Authors:  Weibing Dong; Xiaoman Mao; Yue Guan; Yao Kang; Dejing Shang
Journal:  Sci Rep       Date:  2017-01-05       Impact factor: 4.379

4.  Anti-candidal activity of a novel peptide derived from human chromogranin A and its mechanism of action against Candida krusei.

Authors:  Rui-Fang Li; Xiao-Hui Yan; Yan-Bo Lu; Ya-Li Lu; Hui-Ru Zhang; Shi-Hua Chen; Shuai Liu; Zhi-Fang Lu
Journal:  Exp Ther Med       Date:  2015-09-07       Impact factor: 2.447

Review 5.  Peptide and non-peptide mimetics as potential therapeutics targeting oral bacteria and oral biofilms.

Authors:  Maryta N Sztukowska; Mohammad Roky; Donald R Demuth
Journal:  Mol Oral Microbiol       Date:  2019-08-15       Impact factor: 3.563

6.  A Rapid Fluorescence-Based Microplate Assay to Investigate the Interaction of Membrane Active Antimicrobial Peptides with Whole Gram-Positive Bacteria.

Authors:  Gerard Boix-Lemonche; Maria Lekka; Barbara Skerlavaj
Journal:  Antibiotics (Basel)       Date:  2020-02-19

7.  In Vitro & In Vivo Studies on Identifying and Designing Temporin-1CEh from the Skin Secretion of Rana chensinensis as the Optimised Antibacterial Prototype Drug.

Authors:  Zhuming Ye; Xiaowei Zhou; Xinping Xi; Yu Zai; Mei Zhou; Xiaoling Chen; Chengbang Ma; Tianbao Chen; Lei Wang; Hang Fai Kwok
Journal:  Pharmaceutics       Date:  2022-03-10       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.